154 related articles for article (PubMed ID: 35281881)
1. Prognostic Effect of Subclassification on Oncological Outcomes in Patients with Surgically Treated Localized Papillary Renal Cell Carcinoma: A Retrospective Propensity Score-matched Cohort Study.
Li S; Liu X; Chen X
J Cancer; 2022; 13(4):1193-1202. PubMed ID: 35281881
[No Abstract] [Full Text] [Related]
2. Clinicopathological Features of Papillary Renal Cell Carcinoma With Venous Tumor Thrombus: Case Series from a Large Chinese Center.
Liu Z; Ge L; Zhao X; Lu M; Aili A; Li Y; Zhu G; Hong P; Tian X; Wang S; Zhang H; Liu C; Ding Z; Zhang S; Ma L
Clin Med Insights Oncol; 2022; 16():11795549221092217. PubMed ID: 35465470
[TBL] [Abstract][Full Text] [Related]
3. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
Kim KH; You D; Jeong IG; Kwon TW; Cho YM; Hong JH; Ahn H; Kim CS
BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinicopathologic parameters and oncologic outcomes between type 1 and type 2 papillary renal cell carcinoma.
Le X; Wang XB; Zhao H; Chen RF; Ge P
BMC Urol; 2020 Sep; 20(1):148. PubMed ID: 32933514
[TBL] [Abstract][Full Text] [Related]
5. The Clinicopathological Features and Prognosis in Patients With Papillary Renal Cell Carcinoma: A Multicenter Retrospective Study in Chinese Population.
Hong B; Hou H; Chen L; Li Z; Zhang Z; Zhao Q; Du X; Li Y; Ye X; Xu W; Liu M; Zhang N
Front Oncol; 2021; 11():753690. PubMed ID: 34621685
[TBL] [Abstract][Full Text] [Related]
6. The effect of the papillary renal cell carcinoma subtype on oncological outcomes.
Pan H; Ye L; Zhu Q; Yang Z; Hu M
Sci Rep; 2020 Dec; 10(1):21073. PubMed ID: 33273677
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological Features and Prognostic Outcomes of Papillary Renal Cell Carcinoma.
Qian X; Wan J; Qian C; Zhang J
Int J Gen Med; 2021; 14():7523-7531. PubMed ID: 34754225
[TBL] [Abstract][Full Text] [Related]
8. The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery.
Bigot P; Bernhard JC; Gill IS; Vuong NS; Verhoest G; Flamand V; Reix B; Suer E; Gökce I; Beauval JB; Nouhaud FX; Eto M; Baco E; Matsugasumi T; Chowaniec Y; Rigaud J; Lenormand C; Pfister C; Hetet JF; Ploussard G; Roupret M; Léon P; Bakri AE; Larré S; Tillou X; Doerfler A; Descazeaud A; Koutlidis N; Schneider A; Sebe P; Ingels A; Azzouzi AR; Soulié M; Méjean A; Bensalah K; Patard JJ;
World J Urol; 2016 Mar; 34(3):347-52. PubMed ID: 26149352
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological features and prognostic analysis of papillary renal cell carcinoma].
Bo ES; Hong P; Zhang Y; Deng SH; Ge LY; Lu M; Li N; Ma LL; Zhang SD
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):615-620. PubMed ID: 35950382
[TBL] [Abstract][Full Text] [Related]
10. Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma.
Basile G; Rosiello G; Larcher A; Fallara G; Martini A; Re C; Cignoli D; Tian Z; Karakiewicz PI; Mottrie A; Bertini R; Necchi A; Raggi D; Salonia A; Briganti A; Montorsi F; Capitanio U
Urol Oncol; 2022 Aug; 40(8):384.e15-384.e21. PubMed ID: 35662498
[TBL] [Abstract][Full Text] [Related]
11. Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery.
Ledezma RA; Negron E; Paner GP; Rjepaj C; Lascano D; Haseebuddin M; Dangle P; Shalhav AL; Crist H; Raman JD; Joel DeCastro G; Harik L; Paroder M; Uzzo RG; Kutikov A; Eggener SE
World J Urol; 2016 May; 34(5):687-93. PubMed ID: 26407582
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Subclassification of Papillary Renal Cell Carcinoma: Comparison of Clinicopathologic Parameters and Oncologic Outcomes Between Papillary Histologic Subtypes 1 and 2 Using the Korean Renal Cell Carcinoma Database.
Ha YS; Chung JW; Choi SH; Lee JN; Kim HT; Kim TH; Chung SK; Byun SS; Hwang EC; Kang SH; Hong SH; Chung J; Kwak C; Kim YJ; Kwon TG;
Clin Genitourin Cancer; 2017 Apr; 15(2):e181-e186. PubMed ID: 27595560
[TBL] [Abstract][Full Text] [Related]
13. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
14. High CENPA expression in papillary renal cell carcinoma tissues is associated with poor prognosis.
Li J; Li Q; Yuan Y; Xie Y; Zhang Y; Zhang R
BMC Urol; 2022 Sep; 22(1):157. PubMed ID: 36163007
[TBL] [Abstract][Full Text] [Related]
15. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.
Margulis V; Tamboli P; Matin SF; Swanson DA; Wood CG
Cancer; 2008 Apr; 112(7):1480-8. PubMed ID: 18240184
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Histological Variants on Oncological Outcomes After Surgical Resection of a Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus: A Multi-institutional Study.
Fleury R; Bertail T; Bensalah K; Bernhard JC; Audenet F; Waeckel T; Parier B; Champy C; Olivier J; Doumerc N; Tricard T; Branger N; Bruyere F; Neuville P; Surlemont L; Alexandre Long J; Fontenil A; Vallee M; Roupret M; Boissier R; Jacques Patard J; Durand M; Ouzaid I; Rouget B; Durand X; Joncour C; Belas O; Denise Gomez F; Bigot P; Khene ZE;
Eur Urol Open Sci; 2024 Apr; 62():123-130. PubMed ID: 38496822
[TBL] [Abstract][Full Text] [Related]
17. Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome.
Cornejo KM; Dong F; Zhou AG; Wu CL; Young RH; Braaten K; Sadow PM; Nielsen GP; Oliva E
Hum Pathol; 2015 Oct; 46(10):1411-7. PubMed ID: 26297250
[TBL] [Abstract][Full Text] [Related]
18. Whether histologic subtyping affect the oncological outcomes of patients with papillary renal cell carcinoma: evidence from a systematic review and meta-analysis.
Xiong S; Zhu W; Li X; Yu Y; Yang K; Zhang L; Mi Y; Li X; Zhou L
Transl Androl Urol; 2021 Aug; 10(8):3255-3266. PubMed ID: 34532250
[TBL] [Abstract][Full Text] [Related]
19. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
[TBL] [Abstract][Full Text] [Related]
20. High WHO/ISUP Grade and Unfavorable Architecture, Rather Than Typing of Papillary Renal Cell Carcinoma, May Be Associated With Worse Prognosis.
Yang C; Shuch B; Kluger H; Humphrey PA; Adeniran AJ
Am J Surg Pathol; 2020 May; 44(5):582-593. PubMed ID: 32101890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
